Validity and Clinical Utility of Neuroleptic-Facilitated Electroencephalography in Psychotic Patients

Helmchen H. , Significance of psychotropic drug-induced abnormal EEGs, in Itil T.M. (ed): Psychotropic Drugs and the Human EEG, Basel, S. Karger, 1974, pp 317–326.

Borenstein P. , and Cujo P. , Effects of major tranquilizers on the resting EEG, In Itil T.M. (ed): Psychotropic Drugs and the Human EEG, Basel, S. Karger, 1974, pp 1–21.

Müller H. , and Müller A. , Effects of some psychotropic drugs upon brain electrical activity, Int. J. Neuropsychiatry, 1:224–232, 1965.

Davies R.K. Neil J.F. , and Himmelhoch J.M. , Cerebral dysrhythmias in schizophrenics receiving phenothiazines, Clin. Electroenceph., 6:103–115, 1973.

Steiner W. , and Pollack S. , Limited usefulness of EEG as a diagnostic aid in psychiatric cases receiving tranquilizing drug therapy, Prog. Brain Res., 16:97–105, 1965.

Itil T. , Electroencephalography and pharmacopsychiatry, In Freyhan F. (eds.): Modern Problems of Pharmacopsychiatry, Vol. 1, Basel, S. Karger, 1968, pp 163–194.

Ulett G. , The effect of psychotropic drugs on the EEG of the chronic psychotic patient. In Wilson W.P. (ed.): Applications of Electroencephalography in Psychiatry, Durham, Duke Univ. Press, 1965, pp 241–257.

Serafetinides E.A. , Consistency and similarity of drug-EEG responses in chronic schizophrenic patients, Int. Pharmacopsychiat., 8:214–216, 1973.

Bente D. , Elektroencephalographie und Psychiatrische Pharmakotherapie, In Achelis J.D. , and v. Ditfurth H. (eds.): Anthropologische und Naturwissenschaftliche-klinische Grundlagenprobleme der Pharmakopsychiatrie, Stuttgart, G. Thieme, 1963, pp 75–97.

Winfield D. , and Aivazian G. , EEG changes associated with intensive promazine therapy, Amer. Practitioner, 10:1182–1188, 1959.

Dalen P. , Family history, the electroencephalogram, and perinatal factors in manic conditions, Acta Psychiat. Scand., 41:527–563, 1965.

Talbot D. , Use of intramuscular chlorpromazine to facilitate electroencephalography in psychiatric patients, Electroenceph. Clin. Neurophysiol., 10:358–359, 1958.

Turner M. Berard E. , Modifications électroencephalographiques, électrodermographiques, et électromyographiques provoqueés par la chlorpromazine ches l'homme, Electroenceph. Clin. Neurophysiol., 8:25–39, 1956.

Bente D. , and Itil T. , Chlorpromazine sleep as an electroencephalographic activation method, Electroenceph. Clin. Neurophysiol., 9:355, 1957.

Stewart L. , Chlorpromazine: Use to activate electroencephalographic seizure patterns, Electroenceph. Clin. Neurophysiol., 9:427–440, 1957.

Mayr F. , and Lechner H. , Zur Frage der Provokation bei Temporallappen-Epilepsie im EEG, Wien. Klin. Wschr., 66:903–906, 1954.

Dasberg H. , EEG as an outcome measure in treatment with antipsychotic psychopharmaca, In Itil T.M. (ed.): Psychotropic Drugs and the Human EEG, Basel, S. Karger, 1974, pp 301–316.

Monroe R. , and Mickle W. , Alpha chloralose-activated electroencephalograms in psychiatric patients, J. Nerv. Ment. Dis., 144:59–68, 1967.

Yamada T. , Heterogeneity of schizophrenia as demonstrable in electroencephalography, In Mitsuda H. (ed.): Clinical Genetics in Psychiatry, Tokyo, Igaku Shoin Ltd., 1967, pp 197–208.

Neil J.F. Getzie I. , and Horn T.L. , Patterns of utilization of a neuropsychiatric assessment unit, Hosp. Community Psychiatry (in press).

Feighner J.P. Robins E. Guze S.B. , Diagnostic criteria for use in psychiatric research, Arch. Gen. Psychiat., 26:57–63, 1972.

Spitzer R.L. Endicott J. , and Robins E. , Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, New York, Biometric Research, New York State Psychiatric Institute, 1975.

Kupfer D.J. , and Detre T.P. , Development and application of the KSD™-1 in inpatient and outpatient settings, Psychol. Rep., 29:607–617, 1971.

Kupfer D.J. , and Detre T.P. , KDS™ Systems, Inc., New Haven, Conn., 1971.

Gibbs F. , and Gibbs E. , Atlas of Electroencephalography, Vols. 1–3, Cambridge/Reading, Mass., Addison-Wesley Press, 1950–1964.

Bruck M. , and McNeal B. , Artefacts in the EEG of schizophrenic patients, Am. J. Psychiatry, 121:265–266, 1964.

Emde R.N. , and Metcalf D.R. , EEG signs of toxicity in schizophrenics on phenothiazines, Behav. Neuropsychiatry, 1:31–36, 1969.

Visser S.L. Van Der Horst L. , and Hern-Green H. , Clinical observation and pathophysiological aspects concerning the organic origin of the paradoxical reaction to neuroleptics, Neuropsychopharmacol., 4:463–467, 1964.

Struve F.A. , The necessity and value of securing routine electroencephalograms in psychiatric patients, Clin. Electroenceph., 7:115–130, 1976.

Himmelhoch J.M. , What is schizophrenia? In Bergsma D. and Goldstein A.L. (eds.): Immunologic Components in Schizophrenia, New York, Liss Publ. Co., 1977 (in press).

Rochford J. Detre T. Tucker G. , Neuropsychological impairments in functional psychiatric diseases, Arch. Gen. Psychiatry, 22: 114–119, 1970.

Bellak L. , A possible subgroup of the schizophrenic syndrome and implications for treatment, Am. J. Psychotherapy, 30:194–205, 1976.

Quitkin F. Rifkin A. , and Klein D.F. , Neurologic soft signs in schizophrenia and character disorders: Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders, Arch. Gen. Psychiatry, 33:845–853, 1976.

Tucker G. Detre T. Harrow M. , and Glaser G. , Behavior and symptoms of psychiatric patients and the electroencephalogram. Arch. Gen. Psychiatry, 12:278–286, 1965.

Struve F.A. , EEG findings detected in routine screening of psychiatric patients—Relationship to prior expectation of positive results, Clin. Electroenceph., 8:47–50, 1977.

Legg N.J. , and Swash M. , Clinical note: Seizures and EEG activation after trimipramine, Epilepsia, 15:131–135, 1974.